BioRePeelCl3 FND 5x6ml
Important Notice
Medical device regulated by the European Medical Device Regulation (MDR), intended exclusively for authorized healthcare professionals. By purchasing, the customer declares to be authorized for their professional activity; false information may entail legal responsibilities.
BioRePeelCl3® FND is a biphasic medical peel with 35 % trichloroacetic acid, formulated by CMed Aesthetics for the face, neck and décolletage. Its two-phase architecture — lipophilic and hydrophilic — allows the exfoliating and biostimulating action of TCA without visible desquamation or downtime. The first peel in the aesthetic sector with CE certification under the MDR Regulation.
- TCA 35 %
- Formula biphasic
- Action time 3–5 min
- Contents 5 vials × 6 ml
- MDR certified
Composition and biphasic technology
The product is presented as two non-miscible superimposed phases within the vial. It must be shaken before use until a homogeneous green colour is obtained — this is the visual check for a correct emulsion.
| Lipophilic phase (blue, upper) | Squalane and isopropyl myristate. Acts as a vehicle: it increases penetration, biostimulates the fibroblasts and activates the production of collagen and elastin. |
|---|---|
| Hydrophilic phase (yellow, lower) | TCA 35 %, acids, amino acids, vitamins and GABA. It provides the exfoliating, antioxidant and moisturising action. |
Components of the formula:
- Acids: trichloroacetic (35 %), lactobionic, salicylic, tartaric, citric and GABA
- Amino acids: glycine, proline, hydroxyproline and arginine
- Vitamins: C (ascorbic acid) and B2 (riboflavin)
The oily phase forms an occlusive film that modulates the release of the TCA: hence the effect of trichloroacetic acid without the desquamation characteristic of a classical medical peel.
Indications and treatment areas
Indications: loss of tone and firmness, uneven texture, fine lines, enlarged pores, acne-prone skin and post-acne marks, lack of radiance.
FND areas: face, neck and décolletage.
The manufacturer's protocol also covers hands, elbows, knees, buttocks and feet, as well as other body areas at the practitioner's discretion.
Suitable for all skin types and for use throughout the year.
Treatment protocol
- Preparation: shake the vial until a homogeneous green colour is obtained. Cleanse and degrease the area.
- Withdrawal: with a syringe and 18G cannula. Application with nitrile gloves.
- Application: massage until absorbed.
- Contact time: 3 to 5 minutes for FND.
- Removal: clean the area with a gauze soaked in water. No chemical neutralisation is required.
- Dosage: face 1.5–2.0 ml · neck 1.0–1.5 ml · décolletage 2.0–2.5 ml.
- Full protocol: 4 to 6 sessions with an interval of 7 to 12 days.
- Session duration: approximately 15 minutes.
A full application of face, neck and décolletage uses between 4.5 and 6.0 ml, that is, approximately one vial.
Aftercare: for 2 weeks avoid sun exposure, swimming pool, sauna, waxing and laser, and cosmetics with active ingredients. SPF 50+ sun protection.
Variants of the range
| BioRePeelCl3® FND | TCA 35 % · 5 vials × 6 ml (30 ml) · face, neck and décolletage · contact time 3–5 min · interval 7–12 days |
|---|---|
| BioRePeelCl3® BODY | TCA 50 % · 3 vials × 12 ml (36 ml) · back, shoulders, buttocks, legs, knees, elbows, hands and feet · contact time 5–10 min · interval 10–15 days |
Technical data
| Manufacturer | CMed Aesthetics S.r.l., Italy |
|---|---|
| Principal active substance | Trichloroacetic acid 35 % |
| Type of formulation | Biphasic (lipophilic phase + hydrophilic phase) |
| Route of application | Topical |
| Presentation | 5 sterile vials of 6.0 ml (30 ml in total) |
| Contact time | 3–5 minutes |
| Recommended sessions | 4–6, with an interval of 7–12 days |
| Classification | Topical medical device with CE marking; EU MDR certification (Regulation 2017/745) obtained in November 2024 |
| Use | Qualified healthcare professionals only |
Storage
- Storage: between +5 °C and +25 °C, protected from direct light and from heat. Do not freeze.
- Use before the expiry date shown on the vial.
- Sterile vials. Consult the documentation accompanying the product regarding use after opening.
Contraindications and warnings
Contraindications: pregnancy and breastfeeding; treatment with isotretinoin in the last 6–8 months; autoimmune diseases; active bacterial, viral or fungal infections and open wounds in the area; inflammatory dermatoses (psoriasis, atopic dermatitis); a history of skin cancer with less than 3 years free of recurrence; incomplete post-surgical healing; allergy to salicylates or to TCA; keloid tendency; uncontrolled diabetes.
Caution: a history of herpes simplex (consider antiviral prophylaxis), chronic allergies, tattoos, naevi or warts in the area, ongoing antibiotic therapy, recent laser treatment.
Always consult the instructions for use included in the pack before application.
Medical device intended exclusively for qualified healthcare professionals. Technical information based on the official documentation of CMed Aesthetics (product data sheet and protocol of use). This data sheet does not replace the instructions for use accompanying the product.